Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.
説明 | SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease. |
分子量 | 329.48 |
分子式 | C20H31N3O |
CAS No. | 1629138-41-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (166.93 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SRI-011381 1629138-41-5 Stem Cells TGF-beta/Smad Transforming growth factor beta inhibit multiple neuroprotective NALP3 collagen-1 SRI011381 TGF-β sclerosis Inhibitor SRI 011381 α-SMA inhibitor